BioSpace News Archive

Actelion Pharmaceuticals US, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today an interim analysis from the Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR) study of OPSUMIT®

Dr. Brown’s, makers of the top pediatrician-recommended and no. 1 best-selling bottle in America, is excited to announce its new Dr. Brown’s Natural Flow® Options+™ Anti-Colic Bottles.

Timeshifter® - The Jet Lag App® - today announced it will finalize $1.45 million in seed financing, and that it was selected to join the latest group of travel startups by celebrated Silicon Valley startup accelerator, investor, and corporate innovation platform Plug and Play.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced it will present three abstracts supporting the use of implantable neuromodulation technology to treat chronic heart failure during the American College of Cardiology 68th Annual Scientific Session (ACC 2019) from March 16-18 in New Orleans, USA.

The Laborers’ International Union of North America Midwest Region (LiUNA) has joined the growing coalition of 60 businesses and organizations advocating passage of the Path to 100 Act (SB1781 / HB 2966) legislation to sustain and strengthen Illinois’ renewable energy industry.

McKnight’s Senior Living announced CareOne Executive Vice President Elizabeth Straus has been honored as a Hall of Honor Woman of Distinction.

Blackstone (NYSE: BX) announced today that private equity funds managed by Blackstone (“Blackstone”) have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation

Former Baltimore County Drug Czar, Mike Gimbel, has partnered up with Amatus Health, a national behavioral health organization based in Owings Mills, Maryland.

The International Space Station (ISS) U.S. National Laboratory announced a Request for Proposals (RFP) for investigators seeking biological specimens from mice to support fundamental biological and biomedical inquiries related to the effects of age on health after exposure to microgravity.

Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) (OMX: MOB) today held an Extraordinary General Meeting in the Company’s premises in Bromma.